CD8A and neoplasm: To detect how anti-PD-1 or anti-CTLA-4 checkpoint blockade would interfere in the above cycle, we used a 3-D spheroid system (41) that includes tumor spheroids and CD8+ T cells from MC38 cancer-developing donors as described in Figure 4A.